Kazia Therapeutics KZIA
NASDAQ KZIA
$9.27 -0.20 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Price to Sales (2013 - 2016)

Updated

Kazia Therapeutics' (KZIA) Price to Sales stood at 1718.28 in the year ended Jun 30, 2025, compared with 56.00 a year earlier.

Analysis

Kazia Therapeutics (KZIA) Price to Sales (2013 - 2016) Analysis & Trends

Starting with the year ended Jun 30, 2009, Kazia Therapeutics' Price to Sales history includes 13 years.

  • The figure for the year ended Jun 30, 2025 is the highest annual Price to Sales since the year ended Jun 30, 2018.
  • Per Business Quant data, KZIA's Price to Sales was 56.00 in the year ended Jun 30, 2024 and 229.56 in the year ended Jun 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Kazia Therapeutics 68.33 Mn 68.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 625.71
Dec 31, 2013 521.64
Aug 30, 2013 509.42
API Access

Kazia Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=KZIA&period=max&api_key=YOUR_API_KEY